» Articles » PMID: 29028813

Evaluation of Shedding, Tissue Burdens, and Humoral Immune Response in Goats After Experimental Challenge with the Virulent Brucella Melitensis Strain 16M and the Reduced Virulence Vaccine Strain Rev. 1

Overview
Journal PLoS One
Date 2017 Oct 14
PMID 29028813
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Brucella melitensis is the causative agent of brucellosis in small ruminants and is of considerable economic and public health importance in many countries worldwide. The control of disease in humans depends on the control of disease in livestock; however, few counties with endemic B. melitensis infection have been able to successfully eradicate this pathogen. This underscores the need for further research on the pathogenesis of both virulent and vaccine strains of B. melitensis in the small ruminant host. The aim of the present study was to characterize clinical effects, tissue colonization, shedding, and humoral immune response following B. melitensis infection in goats. Both virulent (16M) and reduced virulence (Rev. 1) strains of B. melitensis were studied. Pregnant goats were infected at 11-14 weeks of gestation with 8 x 106 or 8 x 107 CFU of B. melitensis. Infection of goats with B. melitensis 16M resulted in an 86% abortion rate. This strain disseminated widely in pregnant does post-infection with none of the 15 sampled tissues spared from colonization. Importantly, we report the first isolation of B. melitensis from muscle tissue in ruminants. Pathogenesis of Rev. 1 infection was variable with two does showing minimal colonization and one doe exhibiting disease similar to that of animals infected with fully virulent 16M. Shedding of B. melitensis in milk occurred in all 16M- and Rev. 1- infected goats. In pregnant animals challenged with virulent B. melitensis, median time to seroconversion was 21 days; however, 2 animals did not seroconvert until after abortion.

Citing Articles

Detection and Molecular Diversity of in Pastoral Livestock in North-Eastern Ethiopia.

Sibhat B, Adamu H, Asmare K, Lindahl J, Magnusson U, Tessema T Pathogens. 2025; 13(12.

PMID: 39770323 PMC: 11728775. DOI: 10.3390/pathogens13121063.


Seropositivity and Associated Risk Factors in Pastoral Livestock System in Northeastern Ethiopia.

Sibhat B, Adamu H, Benti T, Tuli G, Asmare K, Lindahl J Vet Sci. 2024; 11(12).

PMID: 39728960 PMC: 11680144. DOI: 10.3390/vetsci11120620.


Serological and Molecular Prevalence and Associated Risk Factors in Caprine Brucellosis, Northeastern Thailand.

Rerkyusuke S, Lerk-U-Suke S, Sukon P, Phuektes P Vet Med Int. 2024; 2024:9966352.

PMID: 39479551 PMC: 11524711. DOI: 10.1155/2024/9966352.


Genome-wide analysis of Brucella melitensis growth in spleen of infected mice allows rational selection of new vaccine candidates.

Barbieux E, Potemberg G, Stubbe F, Fraikin A, Poncin K, Reboul A PLoS Pathog. 2024; 20(8):e1012459.

PMID: 39186777 PMC: 11346958. DOI: 10.1371/journal.ppat.1012459.


Rapid and Specific Detection of B. melitensis Targeting BMEI1661 Gene Using Loop-mediated Isothermal Amplification (LAMP) Combined With Lateral Flow immunoassay (LFIA).

Ashmi M, Kumar B, Sanjana , Abhishek , Kumar D, Singh P Curr Microbiol. 2023; 80(11):351.

PMID: 37737317 DOI: 10.1007/s00284-023-03463-1.


References
1.
Pappas G, Akritidis N, Bosilkovski M, Tsianos E . Brucellosis. N Engl J Med. 2005; 352(22):2325-36. DOI: 10.1056/NEJMra050570. View

2.
Troy S, Rickman L, Davis C . Brucellosis in San Diego: epidemiology and species-related differences in acute clinical presentations. Medicine (Baltimore). 2005; 84(3):174-187. DOI: 10.1097/01.md.0000165659.20988.25. View

3.
Meador V, Hagemoser W, DEYOE B . Histopathologic findings in Brucella abortus-infected, pregnant goats. Am J Vet Res. 1988; 49(2):274-80. View

4.
Blasco J . A review of the use of B. melitensis Rev 1 vaccine in adult sheep and goats. Prev Vet Med. 1997; 31(3-4):275-83. DOI: 10.1016/s0167-5877(96)01110-5. View

5.
El Idrissi A, Benkirane A, el Maadoudi M, Bouslikhane M, Berrada J, Zerouali A . Comparison of the efficacy of Brucella abortus strain RB51 and Brucella melitensis Rev. 1 live vaccines against experimental infection with Brucella melitensis in pregnant ewes. Rev Sci Tech. 2001; 20(3):741-7. DOI: 10.20506/rst.20.3.1305. View